Patents by Inventor Nicholas Charles Smith

Nicholas Charles Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7612050
    Abstract: A bisphosphonate for the treatment of osteonecrosis and/or osteonecrosis dissecans. The drug may further he used to prevent the onset of osteonecrosis and/or osetonecrosis dissecans and any complications associated with both diseases.
    Type: Grant
    Filed: August 13, 2008
    Date of Patent: November 3, 2009
    Assignee: The Royal Alexandra Hospital for Children
    Inventors: David Graham Little, Nicholas Charles Smith
  • Publication number: 20090005347
    Abstract: A bisphosphonate for the treatment of osteonecrosis and/or osteonecrosis dissecans. The drug may further be used to prevent the onset of osteonecrosis and/or osteonecrosis dissecans and any complications associated with both diseases.
    Type: Application
    Filed: August 13, 2008
    Publication date: January 1, 2009
    Inventors: David Graham Little, Nicholas Charles Smith
  • Patent number: 7425549
    Abstract: A bisphosphonate for the treatment of osteonecrosis and/or osteonecrosis dissecans. The drug may further be used to prevent the onset of osteonecrosis and/or osteonecrosis dissecans and any complications associated with both diseases.
    Type: Grant
    Filed: December 13, 2001
    Date of Patent: September 16, 2008
    Assignee: The Royal Alexandra Hospital for Children
    Inventors: David Graham Little, Nicholas Charles Smith
  • Publication number: 20050166927
    Abstract: The present invention is related a nasal positive airway pressure device. The nasal device utilises an engagement means located about nasal cannulae to engage and secure the cannulae within the nares of a patient. The engagement means is a nasal scaling flap. The flap in its natural bias is tapered, the wide-open end of which is shaped to conform to the facial contours of a patient's nose around the outside of the nose. Thus in a closed form, the flap provides a cup-like device that is fitted around the patient's nose and prevent the nasal device from falling from the patients nose. In the open form, which allows for placement and fitting of the nasal device, the flap is intended to be in a bent back position to aid insertion of the nasal cannulae into the patient's nares.
    Type: Application
    Filed: November 12, 2002
    Publication date: August 4, 2005
    Inventors: Alastair McAuley, Nicholas Charles Smith, dominic Doyle
  • Publication number: 20040097469
    Abstract: A bisphosphonate for the treatment of osteonecrosis and/or osteonecrosis dissecans. The drug may further be used to prevent the onset of osteonecrosis and/or osteonecrosis dissecans and any complications associated with both diseases.
    Type: Application
    Filed: December 19, 2003
    Publication date: May 20, 2004
    Inventors: David Graham Little, Nicholas Charles Smith